What type of cancer are we dealing with

According to the document, we are dealing with Follicular Lymphoma, specifically:

• It is Stage 4 Follicular Lymphoma with primary site in the neck
• The patient is currently post-CAR-T cell therapy with evidence of low-level residual disease

According to the Leukemia & Lymphoma Society and NCCN Guidelines, Follicular Lymphoma is a type of non-Hodgkin lymphoma (NHL) that is typically slow-growing (indolent). It is one of the most common subtypes of NHL.

The document shows several important characteristics of this patient's specific case:

1. Stage 4 disease (indicating widespread involvement)
2. Recent CAR-T cell therapy (completed in 2024)
3. Complex molecular profile including several mutations (BCL2, DNMT3A, etc.)
4. "Immune desert" tumor environment with high PD-L1 expression

The National Comprehensive Cancer Network (NCCN) Guidelines recognize follicular lymphoma as a distinct entity with specific treatment algorithms, and the American Society of Clinical Oncology (ASCO) provides detailed guidelines for its management, particularly in advanced stages like this patient's case.

I should note that while this is Stage 4 disease, the document indicates the patient is currently in a monitoring phase after CAR-T therapy, with only low-level residual disease present.